XML 50 R39.htm IDEA: XBRL DOCUMENT v3.5.0.2
INTANGIBLE ASSETS, NET (Details) - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2016
Dec. 31, 2015
Finite-Lived Intangible Assets    
Accumulated Amortization $ (170,725) $ (146,081)
Indefinite-Lived Intangible Assets    
Gross Carrying Amount 2,154,554 1,761,332
Net Amount 1,983,829 1,615,251
Hormone therapy drug candidate patents - (pending) [Member]    
Finite-Lived Intangible Assets    
Gross Carrying Amount 903,694 774,165
Net Amount 903,694 774,165
Multiple trademarks for vitamins/supplements [Member]    
Indefinite-Lived Intangible Assets    
Gross Carrying Amount 172,349 157,721
Net Amount 172,349 157,721
OPERA software patent [Member]    
Finite-Lived Intangible Assets    
Gross Carrying Amount 31,951 31,951
Accumulated Amortization (5,492) (4,493)
Net Amount $ 26,459 $ 27,458
Weighted average remaining amortization period 13 years 3 months 13 years 9 months
Development costs of corporate website [Member]    
Finite-Lived Intangible Assets    
Gross Carrying Amount $ 91,743 $ 91,743
Accumulated Amortization (91,743) (91,743)
Net Amount
Approved Hormone Therapy Drug Candidate Patents [Member]    
Finite-Lived Intangible Assets    
Gross Carrying Amount 954,817 705,752
Accumulated Amortization (73,490) (49,845)
Net Amount $ 881,327 $ 655,907
Weighted average remaining amortization period 16 years 6 months 17 years